The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimerʼs disease
Abstract
Inhibition of protein translation is a mode of inducing neuronal apoptosis and neurodegeneration in Alzheimer's disease (AD). Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) terminates global protein translation and induces apoptosis. We examined whether this signaling pathway occurs in degenerating neurons of AD. Brain sections from young individuals, age-matched control individuals and AD patients were examined for immunoreactivity of phosphorylated eIF2alpha by immunohistochemical analysis. While young brain sections did not display and age-matched brain sections have mild immunoreactive positive cells, AD brain sections revealed intense immunoreactivity for phosphorylated eIF2alpha. Most of the phosphorylated eIF2alpha immunoreactive positive neurons have high immunoreactivity for phosphorylated tau using AT8 antibody. Also, intense staining of phosphorylated eIF2alpha is associated vacuoles in degenerating neurons. This phenomenon was also observed for the immunohistochemical staining of phosphorylated PKR (double-stranded RNA-dependent protein kinase), the upstream kinase for eIF2alpha. Activation of PKR-eIF2alpha pathway is considered to be pro-apoptotic. In addition, formation of autophagy is regulated by eIF2alpha kinase. Therefore, it is concluded that phosphorylation of eIF2alpha is associated with the degeneration of neurons in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“eIF2AK2 has been shown to be activated in AD brain (33)”
From An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease (2013) · cites this paper as [33]
In the citing paper
“Some data also showed that phosphorylated PKR and eIF2α co-localized with phosphorylated τ-protein in affected neurons in AD brains [50].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [50]
In the citing paper
“previous reports revealed that phosphorylation of PKR and eIF2α was associated with degenerating neurons in AD brains [50, 95, 96].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [50]
In the citing paper
“Several studies revealed an increased PKR expression with ageing [47] or in neurodegenerative diseases such as AD, Parkinson's disease, Huntington's disease [48–50]”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [50]
In the citing paper
“In brains of AD patients, Pt451-PKR was also localized in nuclei and around amyloid deposits but the Braak score was not indicated in papers [50, 95].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [50]
In the citing paper
“The control of translation through PKR/eIF2a signalling pathway is altered in AD lymphocytes as it was observed in brains of AD patients [50, 95].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [50]
In the citing paper
“Paradoxically, the up-regulation of PKR in mononuclear cells do not lead to the cell death observed in cellular models exposed to Ap, in AD transgenic mice and in brains of AD patients [50, 95, 97].”
From PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease (2009) · cites this paper as [50]
In the citing paper
“Increased eIF2α correlates with increased p‐eIF2α in AD as previously reported 17, 34, 49, 50.”
From Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome (2016) · cites this paper as [17]
Citations
Cites
PKR; a sentinel kinase for cellular stress
Williams, B. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203127 · Cited by 820
Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway
Tallóczy, Z., Jiang, W., Virgin, H. W., Leib, D. A., Scheuner, D., Kaufman, R. J., Eskelinen, E., & Levine, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012485299 · Cited by 757
Stadelmann, C., Deckwerth, T. L., Srinivasan, A. N., Bancher, C., Brück, W., Jellinger, K. A., & Lassmann, H. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65460-0 · Cited by 432
Frerichs, K. U., Smith, C. B., Brenner, M., DeGracia, D. J., Krause, G. S., Marrone, L., Dever, T. E., & Hallenbeck, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14511 · Cited by 326
Su, J. H., Zhao, M., Anderson, A. J., Srinivasan, A. N., & Cotman, C. W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02018-2 · Cited by 260
Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERK
Kumar, R., Azam, S. M., Sullivan, J. M., Owen, C. R., Cavener, D. R., Zhang, P., Ron, D., Harding, H. P., Chen, J.-J., Han, A., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00387.x · Cited by 212
Boutajangout, A., Leroy, K., Authelet, M., Anderton, B. H., Brion, J., & Woodgett, J. R. (2002) · Acta Neuropathologica · doi:10.1007/s004010100435 · Cited by 190
Chang, R. C., Suen, K., Ma, C., Elyaman, W., Ng, H., & Hugon, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01237.x · Cited by 180
Self-citationTranslation Inhibition in Apoptosis
Saelens, X., Kalai, M., & Vandenabeele, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103674200 · Cited by 177
In Situ Immunodetection of Neuronal Caspase-3 Activation in Alzheimer Disease
Selznick, L. A., Holtzman, D. M., Han, B. H., Gökden, M., Srinivasan, A. N., Johnson, E. M., & Roth, K. A. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199909000-00012 · Cited by 160
Research works printed but not linked: 3
- Bondareff, 1991, Am J Pathol, 139, 641
- Hugon, 2000, J Neural Transm Suppl, 59, 125
- Suen, 2002, Soc Neurosci Abstr, 892.1, 1
Cited by
Sorted by citations
Items 101–200 of 289
Tumor progression and the different faces of the PERK kinase
Pytel, D., Majsterek, I., & Diehl, J. A. (2015) · Oncogene · doi:10.1038/onc.2015.178 · Cited by 60
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease
Franco, R., Martínez‐Pinilla, E., Navarro, G., & Zamarbide, M. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.004 · Cited by 61
Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease
Weidling, I. W., & Swerdlow, R. H. (2019) · Biology · doi:10.3390/biology8020039 · Cited by 59
Alvarez‐Castelao, B., Dieck, S. T., Fusco, C. M., Donlin-Asp, P., Perez, J. D., & Schuman, E. M. (2020) · eLife · doi:10.7554/elife.52714 · Cited by 57
The PKR Activator PACT Is Induced by Aβ: Involvement in Alzheimer's Disease
Paquet, C., Mouton‐Liger, F., MEURS, E. F., Mazot, P., Bouras, C., Pradier, L., Gray, F., & Hugon, J. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00520.x · Cited by 58
Self-citationER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease
Sadleir, K. R., Popović, J., & Vassar, R. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005769 · Cited by 61
TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes
LaRocca, T. J., Mariani, A., Watkins, L. R., & Link, C. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104514 · Cited by 61
Ohno, M. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.08.007 · Cited by 55
Buchanan, H. M., Mackay, M., PALMER, K., Tothová, K., Katsur, M., Platt, B., & Koss, D. J. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01950-1 · Cited by 58
Carter, C. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.11.003 · Cited by 54
Hu, Z., Yu, P., Zhang, Y., Yang, Y., Zhu, M., Qin, S., Xu, J., Duan, D.-X., Wu, Y., Wang, D., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01862-9 · Cited by 52
Rheb Inhibits Protein Synthesis by Activating the PERK-eIF2α Signaling Cascade
Tyagi, R., Shahani, N., Gorgen, L., Ferretti, M., Pryor, W., Chen, P. Y., Swarnkar, S., Worley, P. F., Karbstein, K., Snyder, S. H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.014 · Cited by 51
eIF2α phosphorylation controls thermal nociception
Khoutorsky, A., Sorge, R. E., Prager‐Khoutorsky, M., Pawlowski, S. A., Longo, G., Jafarnejad, S. M., Tahmasebi, S., Martin, L. J., Pitcher, M. H., Gkogkas, C. G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614047113 · Cited by 50
Yu, M.-S., Suen, K., Kwok, N.-S., So, K., Hugon, J., & Chang, R. C. (2006) · APOPTOSIS · doi:10.1007/s10495-006-5540-1 · Cited by 52
Self-citationKDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR
Kamimura, D., Katsunuma, K., Arima, Y., Atsumi, T., Jiang, J., Bando, H., Meng, J., Sabharwal, L., Štofková, A., Nishikawa, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms8474 · Cited by 51
Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo
Kim, H., Choi, Y., Shin, K. Y., Joo, Y., Lee, Y., Jung, S. Y., Suh, Y., & Kim, J. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21267 · Cited by 49
Induction of C/EBPβ and GADD153 expression by dopamine in human neuroblastoma cells
Gómez-Santos, C., Barrachina, M., Giménez‐Xavier, P., Dalfó, E., Ferrer, I., & Ambrosio, S. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.008 · Cited by 51
Ohno, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.007 · Cited by 51
Xia, D., Zhang, Z., & Zhao, Y. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00210 · Cited by 49
Tible, M., Mouton‐Liger, F., Schmitt, J., Giralt, A., Farid, K., Thomasseau, S., Gourmaud, S., Paquet, C., Rondi‐Reig, L., MEURS, E. F., et al. (2019) · Aging Cell · doi:10.1111/acel.12887 · Cited by 48
Self-citationDifferential Activation of the ER Stress Factor XBP1 by Oligomeric Assemblies
Castillo‐Carranza, D. L., Zhang, Y., Guerrero‐Munoz, M. J., Kayed, R., Rincón-Limas, D. E., & Fernández-Fúnez, P. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0780-7 · Cited by 51
PKR, the double stranded RNA‐dependent protein kinase as a critical target in Alzheimer's disease
Morel, M., Couturier, J., Lafay‐Chebassier, C., Paccalin, M., & Page, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00849.x · Cited by 47
Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration
Qu, Z., Mossine, V. V., Cui, J., Sun, G. Y., & Gu, Z. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8410-1 · Cited by 45
Trivedi, D. K., Ansari, M. W., & Tuteja, N. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.25260 · Cited by 44
Couturier, J., Morel, M., Pontcharraud, R., Gontier, V., Fauconneau, B., Paccalin, M., & Page, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041954 · Cited by 44
Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease
Weber, A. J., & Herskowitz, J. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.636017 · Cited by 42
The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease
Hugon, J., & Paquet, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063136 · Cited by 44
Self-citationTranslational control by eIF2α in neurons: Beyond the stress response
Bellato, H. M., & Hajj, G. N. M. (2016) · Cytoskeleton · doi:10.1002/cm.21294 · Cited by 46
Quercetin Regulates the Integrated Stress Response to Improve Memory
Nakagawa, T., & Ohta, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112761 · Cited by 44
Lin, K., Chang, R. C., Suen, K., So, K., & Hugon, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03245.x · Cited by 44
Self-citationAlzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 43
eIF2-dependent translation initiation: Memory consolidation and disruption in Alzheimer’s disease
Oliveira, M. M., & Klann, E. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.07.009 · Cited by 43
Porphyromonas gingivalis-Induced Neuroinflammation in Alzheimer’s Disease
Olsen, I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.691016 · Cited by 41
Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death
Reimer, L., Vesterager, L. B., Betzer, C., Zheng, J., Nielsen, L. D., Kofoed, R. H., Lassen, L. B., Bølcho, U., Paludan, S. R., Fog, K., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.001 · Cited by 42
Deguil, J., Jailloux, D., Page, G., Fauconneau, B., Houéto, J., Philippe, M., Jm, M., & Pain, S. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21318 · Cited by 42
Double stranded RNA activated EIF2 α kinase (EIF2AK2; PKR) is associated with Alzheimer's disease
Bullido, M. J., Martínez-García, A., Tenorio, R., Sastre, I., Muñoz, D. G., Frank, A., & Valdivieso, F. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.023 · Cited by 51
Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond
Agyemang, A. F., Harrison, S. R., Siegel, R. M., & McDermott, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0496-2 · Cited by 41
PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model
Mouton‐Liger, F., Rebillat, A.-S., Gourmaud, S., Paquet, C., Leguen, A., Dumurgier, J., Bernadelli, P., Taupin, V., Pradier, L., Rooney, T., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.552 · Cited by 40
Self-citationPim1 inhibition as a novel therapeutic strategy for Alzheimer’s disease
Velázquez, R., Shaw, D. M., Caccamo, A., & Oddo, S. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0118-z · Cited by 39
Stress granule formation helps to mitigate neurodegeneration
Glineburg, M. R., Yildirim, E., Gómez, N., Rodriguez, G., Pak, J., Li, X., Altheim, C. H., Waksmacki, J., McInerney, G. M., Barmada, S. J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae655 · Cited by 39
Mamada, N., Tanokashira, D., Hosaka, A., Kametani, F., Tamaoka, A., & Araki, W. (2015) · Molecular Brain · doi:10.1186/s13041-015-0163-5 · Cited by 40
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
Milisav, I., Šuput, D., & Ribarič, S. (2015) · Molecules · doi:10.3390/molecules201219865 · Cited by 42
PKR kinase directly regulates tau expression and Alzheimer's disease‐related tau phosphorylation
Reimer, L., Betzer, C., Kofoed, R. H., Volbracht, C., Fog, K., Kurhade, C., Nilsson, E., Överby, A. K., & Jensen, P. H. (2020) · Brain Pathology · doi:10.1111/bpa.12883 · Cited by 39
Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer’s disease
Devi, L., & Ohno, M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.59 · Cited by 38
Poly-ubiquitin profile in Alzheimer disease brain
Tramutola, A., Triani, F., Domenico, F. D., Barone, E., Cai, J., Klein, J. B., Marzia Perluigi, A., & Butterfield, D. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.006 · Cited by 38
Mitochondrial retrograde signalling in neurological disease
Granat, L., Hunt, R. J., & Bateman, J. M. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0415 · Cited by 37
MARK2 phosphorylates eIF2α in response to proteotoxic stress
Lu, Y., Kavianpour, S. M., Zhang, T., Zhang, X., Nguyen, D. K. H., Thombre, R., He, L., & Wang, J. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001096 · Cited by 39
A combination Alzheimer’s therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice
Devi, L., & Ohno, M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0110-5 · Cited by 37
Autophagy--a basic mechanism and a potential role for neurodegeneration.
Bursch, W., & Ellinger, A. (2005) · PubMed · Cited by 37
Morel, M., Couturier, J., Pontcharraud, R., Gil, R., Fauconneau, B., Paccalin, M., & Page, G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.004 · Cited by 36
Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules
Lanzillotta, C., & Domenico, F. D. (2021) · Biomolecules · doi:10.3390/biom11020266 · Cited by 36
Low molecular weight Aβ induces collapse of endoplasmic reticulum
Lai, C. S.-W., Preisler, J., Baum, L., Lee, D. H.-S., Ng, H., Hugon, J., So, K., & Chang, R. C. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.01.006 · Cited by 35
Self-citationLopez‐Grancha, M., Bernardelli, P., Moindrot, N., Genet, E., Vincent, C., Roudières, V., Krick, A., Sabuco, J.-F., Machnik, D., Ibghi, D., et al. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000590 · Cited by 34
Paesler, K., Xie, K., Hettich, M. M., Siwek, M. E., Ryan, D. P., Schröder, S., Papazoglou, A., Broich, K., Müller, R., Trog, A., et al. (2015) · Neural Plasticity · doi:10.1155/2015/825157 · Cited by 36
Burnett, S. B., Vaughn, L. S., Sharma, N., Kulkarni, R., & Patel, R. C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105135 · Cited by 34
Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis
Jeon, Y., Kwon, Y., Lee, S., & Kim, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1047897 · Cited by 34
Rios-Fuller, T. J., Mahé, M., Walters, B., Abbadi, D., Pérez-Baos, S., Gadi, A., Andrews, J. J., Katsara, O., Vincent, C. T., & Schneider, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155301 · Cited by 34
The Potential Role of Protein Kinase R as a Regulator of Age-Related Neurodegeneration
Martínez, N. W., Gómez, F. E., & Matus, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.638208 · Cited by 31
Sleep deficiency as a driver of cellular stress and damage in neurological disorders
Coulson, R. L., Mourrain, P., & Wang, G. X. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101616 · Cited by 33
Wen, L., Han, F., Shi, Y., & Li, X. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0755-2 · Cited by 35
Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs
Santini, E., & Klann, E. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00076 · Cited by 34
Damjanac, M., Page, G., Ragot, S., Laborie, G., Gil, R., Hugon, J., & Paccalin, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00688.x · Cited by 31
Self-citationRahman, S., Ayyagari, A., Jan, A. T., & Minakshi, R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00030 · Cited by 33
Caccamo, A., Belfiore, R., & Oddo, S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.032 · Cited by 31
RetractedElder, M. K., Erdjument‐Bromage, H., Oliveira, M. M., Mamcarz, M., Neubert, T. A., & Klann, E. (2021) · Communications Biology · doi:10.1038/s42003-021-02324-6 · Cited by 33
Badía, M.-C., Lloret, A., Giraldo, E., Dası́, F., González, G. O., Alonso, M.-D., & Viña, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120973 · Cited by 30
Rapamycin inhibits lipopolysaccharide-induced neuroinflammation in vitro and in vivo
Mengke, N.-S., Hu, B., Han, Q., Deng, Y., Fang, M., Xie, D., Li, A., & Zeng, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5883 · Cited by 30
Damjanac, M., Rioux Bilan, A., Paccalin, M., Pontcharraud, R., Fauconneau, B., Hugon, J., & Page, G. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.008 · Cited by 32
Self-citationRNA binding proteins in senescence: A potential common linker for age-related diseases?
Varesi, A., Campagnoli, L. I. M., Barbieri, A., Rossi, L., Ricevuti, G., Esposito, C., Chirumbolo, S., Marchesi, N., & Pascale, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101958 · Cited by 29
Inhibition of PKR protects against tunicamycin-induced apoptosis in neuroblastoma cells
Vaughn, L. S., Snee, B., & Patel, R. C. (2013) · Gene · doi:10.1016/j.gene.2013.11.074 · Cited by 30
Díaz, A., Merino, P., Guo, J., Yepes, M., McCann, P., Katta, T., Tong, E. M., Torre, E. R., Rangaraju, S., & Yepes, M. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2804-19.2020 · Cited by 29
Dai, Y., Han, G., Xu, S., Yuan, Y., Zhao, C., & Ma, T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593659 · Cited by 30
Neuronal Phosphorylated RNA-Dependent Protein Kinase in Creutzfeldt-Jakob Disease
Paquet, C., Bose, A., Polivka, M., Peoc’h, K., Brouland, J., Keohane, C., Hugon, J., & Gray, F. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318196cd7c · Cited by 28
Self-citationWen, L., Xiao, B., Shi, Y., & Han, F. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1371-5 · Cited by 28
Majd, R., Mayeli, M., & Rahmani, F. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00600-8 · Cited by 27
Activation of eukaryotic initiation factor-2α-kinases in okadaic acid-treated neurons
Kim, S. M., Yoon, S., Choi, J. E., Park, J. S., Choi, J. M., Nguyen, T. T., & Kim, D. H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.016 · Cited by 26
Unique pharmacological property of ISRIB in inhibition of Aβ-induced neuronal cell death
Hosoi, T., Kakimoto, M., Tanaka, K., Nomura, J., & Ozawa, K. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.08.003 · Cited by 26
Pytel, D., Seyb, K. I., Liu, M., Ray, S. S., Concannon, J. B., Huang, M., Cuny, G. D., Diehl, J. A., & Glicksman, M. A. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114525853 · Cited by 26
Nitric Oxide Influences HSV-1-Induced Neuroinflammation
Cymerys, J., Kowalczyk, A., Mikołajewicz, K., Słońska, A., & Krzyżowska, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2302835 · Cited by 26
Hafycz, J. M., & Naidoo, N. N. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00140 · Cited by 28
Chakrabarty, A., Danley, M., & LeVine, S. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20125 · Cited by 26
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 29
Couturier, J., Page, G., Morel, M., Gontier, C., Lecron, J., Pontcharraud, R., Fauconneau, B., & Paccalin, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100258 · Cited by 26
Satratoxin G–Induced Apoptosis in PC-12 Neuronal Cells is Mediated by PKR and Caspase Independent
Islam, Z., Hegg, C. C., Bae, H. K., & Pestka, J. J. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn110 · Cited by 25
Kammerman, E. M., Neumann, D. M., Ball, M. J., Lukiw, W. J., & Hill, J. M. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.07.033 · Cited by 24
Significance of Molecular Signaling for Protein Translation Control in Neurodegenerative Diseases
Chang, R. C., Yu, M.-S., & Lai, C. S.-W. (2006) · Neurosignals · doi:10.1159/000102599 · Cited by 22
Self-citationThe double-stranded RNA-activated protein kinase mediates viral-induced encephalitis
Scheuner, D. L., Gromeier, M., Davies, M. V., Dorner, A. J., Song, B., Patel, R., Wimmer, E., McLendon, R. E., & Kaufman, R. J. (2003) · Virology · doi:10.1016/j.virol.2003.08.010 · Cited by 23
Could PKR inhibition modulate human neurodegeneration?
Hugon, J., Paquet, C., & Chang, R. C. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.92 · Cited by 23
Self-citationThe Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 22
Augustin, R., Lichtenthaler, S. F., Greeff, M., Hansen, J., Wurst, W., & Trümbach, D. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/154325 · Cited by 23
Rozpędek‐Kamińska, W., Pytel, D., Popławski, T., Walczak, A., Gradzik, K., Wawrzynkiewicz, A., Wojtczak, R., Mucha, B., Diehl, J. A., & Majsterek, I. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228121157 · Cited by 22
The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies
García‐Velázquez, L., & Massieu, L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1214092 · Cited by 21
A Perspective on the Potential Involvement of Impaired Proteostasis in Neuropsychiatric Disorders
Hui, K. K., Endo, R., Sawa, A., & Tanaka, M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.09.001 · Cited by 18
Segev, Y., Livne, A., Mints, M., & Rosenblum, K. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00170 · Cited by 18
He, Z., Wang, M.-H., Zhao, Q., Li, X., Liu, P., Ren, B., Wu, C., Du, X., Li, N., & Liu, Q. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111073 · Cited by 18
Burnett, S. B., Vaughn, L. S., Strom, J. M., Francois, A., & Patel, R. C. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29223 · Cited by 18
Dual Kinase Inhibition Affords Extended in vitro Neuroprotection in Amyloid-β Toxicity
Gourmaud, S., Mouton‐Liger, F., Abadie, C., MEURS, E. F., Paquet, C., & Hugon, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160509 · Cited by 17
Self-citationBlood-Based Kinase Assessments in Alzheimer’s Disease
Hugon, J., Mouton‐Liger, F., Cognat, E., Dumurgier, J., & Paquet, C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00338 · Cited by 16
Self-citationRevealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain
Cho, C., Michailidis, V., & Martin, L. J. (2018) · Neurobiology of Pain · doi:10.1016/j.ynpai.2018.03.002 · Cited by 16
Ho-Tieng, D., Sharma, V. K., Sonenberg, N., Gkogkas, C. G., & Khoutorsky, A. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.08.002 · Cited by 14
Metadata
- Authors
- Chang, R. C. C., Wong, A. K. Y., Ng, H.-K., & Hugon, J.
- Affiliations
- University of Hong Kong (HK)
- Chinese University of Hong Kong (HK)
- Venue
- NeuroReport
- Published
- 2002-12
- Volume
- 13
- Issue
- 18
- Pages
- 2429-2432
- ISSN
- 0959-4965 (ISSN-L)
- OpenAlex
- W2013806485
- Cited by
- 289
- References
- 23
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 11 · 2023: 12 · 2022: 14 · 2021: 21 · 2020: 19 · 2019: 15 · 2018: 17 · 2017: 9 · 2016: 13 · 2015: 24 · 2014: 13 · 2013: 11 · 2012: 13
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroreport (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- eIF2α phosphorylation, Alzheimer's disease, neurodegeneration, protein translation inhibition, neuronal apoptosis, tau phosphorylation, autophagy
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Fluorescent Antibody Technique, Fluorescent Dyes, Humans, Male, Nerve Degeneration, Phosphorylation, Signal Transduction, Eukaryotic Initiation Factor-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review